Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 11.30
+0.13 (1.16%)
Apr 2, 2026, 3:29 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 10.62 billion as of April 2, 2026. Its market cap has decreased by -29.38% in one year.
Market Cap
10.62B
Enterprise Value
9.18B
Revenue
5.03B
Ranking
n/a
PE Ratio
15.40
Stock Price
11.30
Market Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 10.62B, an increase of 3,877.56%. That is a compound annual growth rate of 16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 10.62B | -20.81% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 31.77B |
| Orchid Pharma | 26.57B |
| Solara Active Pharma Sciences | 22.93B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |
| Beta Drugs | 14.00B |
| Jagsonpal Pharmaceuticals | 12.47B |
| Ind-Swift Laboratories | 12.04B |